CD26 is a potential therapeutic target by humanized monoclonal antibody for the treatment of multiple myeloma
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Hematology
Link
http://www.nature.com/articles/s41408-018-0127-y.pdf
Reference61 articles.
1. Palumbo, A. & Anderson, K. Multiple myeloma. New Engl. J. Med 364, 1046–1060 (2011).
2. Moreau, P. & de Wit, E. Recent progress in relapsed multiple myeloma therapy implications for treatment decisions. Br. J. Haematol. 179, 198–218 (2017).
3. Stewart, A. K. et al. Carfilzomib, lenalidomide and dexamethasone for relapsed multiple myeloma. New Engl. J. Med 372, 142–152 (2015).
4. Avet-Loiseau, H. et al. Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myeloma. Blood 128, 1174–1180 (2016).
5. Moreau, P. et al. Oral ixazomib, lenalidomide, and dexamethasone for multiple myeloma. New Engl. J. Med. 374, 1621–1634 (2016).
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. HDAC Inhibition Induces CD26 Expression on Multiple Myeloma Cells via the c-Myc/Sp1-mediated Promoter Activation;Cancer Research Communications;2024-02-09
2. Multiomics surface receptor profiling of the NCI-60 tumor cell panel uncovers novel theranostics for cancer immunotherapy;Cancer Cell International;2022-10-11
3. Therapeutic Perspectives of CD26 Inhibitors in Imune-Mediated Diseases;Molecules;2022-07-14
4. CD26/DPP-4 in Chronic Myeloid Leukemia;Cancers;2022-02-11
5. Validating Cell Surface Proteases as Drug Targets for Cancer Therapy: What Do We Know, and Where Do We Go?;Cancers;2022-01-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3